Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Fox

Showing results (131-140 of 179) with videos related to

Pageof 18
Sort By:
BMJ Open|April 8, 2024
Social prescribing for people living with dementia (PLWD) and their carers: what works, for whom, under what circumstances and why - protocol for a complex intervention systematic reviewJessica Marshall, Evie Papavasiliou, Chris Fox, et al.
The Lancet. Neurology|August 31, 2015
Multimodal imaging in Alzheimer's disease: validity and usefulness for early detectionStefan Teipel, Alexander Drzezga, Michel J Grothe, et al.
BMC Neurology|September 9, 2019
Study protocol: ASCRIBED: the impact of Acute SystematiC inflammation upon cerebRospinal fluId and blood BiomarkErs of brain inflammation and injury in dementia: a study in acute hip fracture patientsNick Leavey, Simon P Hammond, Lee Shepstone, et al.
American Journal of Epidemiology|May 22, 2019
History of Benzodiazepine Prescriptions and Risk of Dementia: Possible Bias Due to Prevalent Users and Covariate Measurement Timing in a Nested Case-Control StudyKathryn Richardson, Katharina Mattishent, Yoon K Loke, et al.
Trials|October 25, 2013
Does telecare prolong community living in dementia? A study protocol for a pragmatic, randomised controlled trialIracema Leroi, John Woolham, Rebecca Gathercole, et al.
Journal of Alzheimer'S Disease : JAD|March 3, 2020
Neuropathological Correlates of Cumulative Benzodiazepine and Anticholinergic Drug UseKathryn Richardson, Stephen B Wharton, Carlota M Grossi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 20, 2023
Impact of the iWHELD digital person-centered care program on quality of life, agitation and psychotropic medications in people with dementia living in nursing homes during the COVID-19 pandemic: A randomized controlled trialJoanne McDermid, William Henley, Anne Corbett, et al.
Bjpsych Open|October 25, 2024
Cost-utility analysis of adapted problem adaptation therapy for depression in mild-to-moderate dementia caused by Alzheimer's disease: PATHFINDER randomised controlled trialMonica Panca, Robert Howard, Elizabeth Cort, et al.
BMJ (Clinical Research Ed.)|April 27, 2018
Anticholinergic drugs and risk of dementia: case-control studyKathryn Richardson, Chris Fox, Ian Maidment, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|May 10, 2025
Reimagining Dementia Care: A Complex Intervention Systematic Review on Optimising Social Prescribing (SP) for Carers of People Living With Dementia (PLWD) in the United KingdomJessica Marshall, Evie Papavasiliou, Louise Allan, et al.
Pageof 18

Showing results (131-140 of 179) with videos related to

Sort By:
Pageof 18
BMJ Open|April 8, 2024
Social prescribing for people living with dementia (PLWD) and their carers: what works, for whom, under what circumstances and why - protocol for a complex intervention systematic reviewJessica Marshall, Evie Papavasiliou, Chris Fox, et al.
The Lancet. Neurology|August 31, 2015
Multimodal imaging in Alzheimer's disease: validity and usefulness for early detectionStefan Teipel, Alexander Drzezga, Michel J Grothe, et al.
BMC Neurology|September 9, 2019
Study protocol: ASCRIBED: the impact of Acute SystematiC inflammation upon cerebRospinal fluId and blood BiomarkErs of brain inflammation and injury in dementia: a study in acute hip fracture patientsNick Leavey, Simon P Hammond, Lee Shepstone, et al.
American Journal of Epidemiology|May 22, 2019
History of Benzodiazepine Prescriptions and Risk of Dementia: Possible Bias Due to Prevalent Users and Covariate Measurement Timing in a Nested Case-Control StudyKathryn Richardson, Katharina Mattishent, Yoon K Loke, et al.
Trials|October 25, 2013
Does telecare prolong community living in dementia? A study protocol for a pragmatic, randomised controlled trialIracema Leroi, John Woolham, Rebecca Gathercole, et al.
Journal of Alzheimer'S Disease : JAD|March 3, 2020
Neuropathological Correlates of Cumulative Benzodiazepine and Anticholinergic Drug UseKathryn Richardson, Stephen B Wharton, Carlota M Grossi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 20, 2023
Impact of the iWHELD digital person-centered care program on quality of life, agitation and psychotropic medications in people with dementia living in nursing homes during the COVID-19 pandemic: A randomized controlled trialJoanne McDermid, William Henley, Anne Corbett, et al.
Bjpsych Open|October 25, 2024
Cost-utility analysis of adapted problem adaptation therapy for depression in mild-to-moderate dementia caused by Alzheimer's disease: PATHFINDER randomised controlled trialMonica Panca, Robert Howard, Elizabeth Cort, et al.
BMJ (Clinical Research Ed.)|April 27, 2018
Anticholinergic drugs and risk of dementia: case-control studyKathryn Richardson, Chris Fox, Ian Maidment, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|May 10, 2025
Reimagining Dementia Care: A Complex Intervention Systematic Review on Optimising Social Prescribing (SP) for Carers of People Living With Dementia (PLWD) in the United KingdomJessica Marshall, Evie Papavasiliou, Louise Allan, et al.
Pageof 18